Lumos Diagnostics provides rapid, cost effective point of care (POC) tests for infectious disease and antimicrobial stewardship. The company’s innovative and patented FebriDx® test is the first and only rapid POC test to differentiate a viral from bacterial acute respiratory infection. With a 99% negative predictive value, FebriDx delivers results in 10 minutes from fingerstick blood and can be used to help rapidly and accurately triage infectious patients in GP Surgeries and other Outpatient settings optimising patient management, improving clinic workflow whilst reducing unnecessary antibiotic prescriptions. In a UK outcome study in a GP setting, FebriDx® was shown to improve the clinical management in 48% of patients and reduce antibiotic prescriptions by 80%.